Introduction Older individuals face an elevated risk of developing bacterial infections. The
optimal use of antibacterial agents in this population is challenging because of age-related …

Infections are important factors contributing to the morbidity and mortality among elderly
patients. High rates of consumption of antimicrobial agents by the elderly may result in …

Although it is now the eighth decade of the antibiotic era, with the commensurate wealth of
data, there are still areas that require greater exploration. The pharmacokinetic (PK), and …

Introduction: The number of elderly people is increasing worldwide. The elderly may be at
increased risk of bacterial infections compared with younger adults. Dosing adaptation of …

Treating infections with antimicrobial agents in older patients can be challenging.
Physiological changes associated with aging can alter the pharmacokinetics of antimicrobial …

Pharmacologic management of infections in elderly patients presents multiple challenges to
health care professionals due to variable pharmacokinetics, pharmacodynamics, and …

The fundamental principles of treating infectious diseases apply to elderly patients, but
certain aspects of therapy such as the selection of empiric regimens and risk stratification for …

Throughout most of the world we are witnessing an ever increasing number of aged people
as a percentage of the general population. In the coming years, the unique spectrum of …

Older patients are at high risk of infections, which often present atypically and are associated
with high morbidity and mortality. Antimicrobial treatment in older individuals with infectious …

Elderly persons consume a significant proportion of health care resources. Antimicrobials
are just one class among many pharmaceuticals that are prescribed more frequently to …